PhenomeX Inc.
PhenomeX Inc. (Nasdaq: CELL), relating to its proposed sale to Bruker Corp. Under the terms of the agreement, CELL shareholders will receive $1.00 in cash per share they own.
PhenomeX Inc. (Nasdaq: CELL), relating to its proposed sale to Bruker Corp. Under the terms of the agreement, CELL shareholders will receive $1.00 in cash per share they own.
Crestwood Equity Partners LP (NYSE: CEQP), relating to its proposed sale to Energy Transfer LP. Under the terms of the agreement, CEQP shareholders will receive 2.07 shares of Energy Transfer per share they own.
Holly Energy Partners, L.P. (NYSE: HEP), relating to its proposed sale to HF Sinclair Corp. Under the terms of the agreement, HEP shareholders are expected to receive 0.315 shares of HF Sinclair common stock and $4.00 in cash per share they own.
Timber Pharmaceuticals, Inc. (NYSE: TMBR), relating to its proposed sale to LEO Pharma A/S.
Computer Task Group, Inc. (Nasdaq: CTG), relating to its proposed sale to Cegeka Groep NV. Under the terms of the agreement, CTG shareholders will receive $10.50 in cash per share they own.
Decibel Therapeutics, Inc. (Nasdaq: DBTX), relating to its proposed acquisition by Regeneron Pharmaceuticals, Inc. Under the terms of the tender offer, DBTX shareholders will receive $4.00 in cash plus one non-tradeable CVR worth up to $3.50 per share they own
Apexigen, Inc. (Nasdaq: APGN), relating to its proposed sale to Pyxis Oncology, Inc. Under the terms of the agreement, APGN shareholders are expected to receive 0.1725 shares of Pyxis per share they own.
Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), relating to its proposed acquisition by Harmony Biosciences Holdings, Inc. Under the terms of the tender offer, ZYNE shareholders are expected to receive $1.1059 in cash plus one non-tradeable CVR per share they own.
Capri Holdings Ltd. (NYSE: CPRI), relating to its proposed sale to Tapestry, Inc. Under the terms of the agreement, CPRI shareholders will receive $27.05 in cash per share they own.
Avid Technology, Inc. (Nasdaq: AVID), relating to its proposed acquisition by an affiliate of STG. Under the terms of the agreement, AVID shareholders will receive $27.05 in cash per share they own.